Immunoprotective activities of multiple chaperone proteins isolated from murine B-cell leukemia/lymphoma

Clinical Cancer Research

Volumn 6, Issue 3, 2000, Pages 909-915

  Graner, Michael ^a   Raymond, Amy ^a   Romney, Davis ^a   He, Lin ^a   Whitesell, Luke ^a   Katsanis, Emmanuel ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALRETICULIN; CANCER VACCINE; CHAPERONE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; B CELL LEUKEMIA; B CELL LYMPHOMA; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; TUMOR IMMUNITY;

3T3 CELLS; ANIMALS; CALCIUM-BINDING PROTEINS; CALRETICULIN; CANCER VACCINES; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HSP70 HEAT-SHOCK PROTEINS; HSP90 HEAT-SHOCK PROTEINS; IMMUNITY; IMMUNIZATION; LEUKEMIA, B-CELL; LYMPHOMA, B-CELL; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MOLECULAR CHAPERONES; RIBONUCLEOPROTEINS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR CELLS, CULTURED;

EID: 0034016788     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Srivastava, P. K., Menoret, A., Basu, S., Binder, R. J., and McQuade, K. L. Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world. Immunity, 8: 657-665, 1998.
2. Arnold-Schild, D., Hanau, D., Spehner, D., Schmid, C., Rammensee, H. G., de la Salle, H., and Schild, H. Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. J. Immunol., 162: 3757-3760, 1999.
3. Nicchitta, C. V. Biochemical, cell biological and immunological issues surrounding the endoplasmic reticulum chaperone GRP94/gp96. Curr. Opin. Immunol., 10: 103-109, 1998.
4. Heike, M., Noll, B., and Meyer zum Buschenfelde, K. H. Heat shock protein-peptide complexes for use in vaccines. J. Leukoc. Biol., 60: 153-158, 1996.
5. Srivastava, P. K., Udono, H., Blachere, N. E., and Li, Z. Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics., 39: 93-98, 1994.
6. Srivastava, P. K., and Maki, R. G. Stress-induced proteins in immune response to cancer. Curr. Top. Microbiol. Immunol., 167: 109-123, 1991.
7. Srivastava, P. K. Peptide-binding heat shock proteins in the endoplasmic reticulum: role in immune response to cancer and in antigen presentation. Adv. Cancer Res., 62: 153-177, 1993.
8. Udono, H., and Srivastava, P. K. Heat shock protein 70-associated peptides elicit specific cancer immunity. J. Exp. Med., 178: 1391-1396, 1993.
9. Suto, R., and Srivastava, P. K. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science (Washington DC), 269: 1585-1588, 1995.
10. Udono, H., Levey, D. L., and Srivastava, P. K. Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo. Proc. Natl. Acad. Sci. USA, 91: 3077-3081, 1994.
11. Kim, K. J., Kanellopoulos-Langevin, C., Merwin, R. M., Sachs, D. H., and Asofsky, R. Establishment and characterization of BALB/c lymphoma lines with B cell properties. J. Immunol., 122; 549-554, 1979.
12. Glass, B., Uharek, L., Gassmann, W., Focks, B., Bolouri, H., Loeffler, H., and Mueller-Ruchholtz, W. Graft-versus-leukemia activity after bone marrow transplantation does not require graft-versus-host disease. Ann. Hematol., 64: 255-259, 1992.
13. Levitsky, H. I., Montgomery, J., Ahmadzadeh, M., Staveley-O'Carroll, K., Guarnieri, F., Longo, D. L., and Kwak, L. W. Immunization with granulocyte-macrophage colony-stimulating factor-transduced, but not B7-1-transduced, lymphoma cells primes idiotype-specific T cells and generates potent systemic antitumor immunity. J. Immunol., 156: 3858-3865, 1996.
14. Felsher, D. W., Denis, K. A., Weiss, D., Ando, D. T., and Braun, J. A murine model for B-cell lymphomagenesis in immunocompromised hosts: c-myc-rearranged B-cell lines with a premalignant phenotype. Cancer Res., 50: 7042-7049, 1990.
15. Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D., and Mulligan, R. C. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA., 90: 3539-3543, 1993.
16. Jaffee, E. M., Dranoff, G., Cohen, L. K., Hauda, K. M., Clift, S., Marshall, F. F., Mulligan, R. C., and Pardoll, D. M. High efficiency gene transfer into primary human tumor explants without cell selection. Cancer Res., 53: 2221-2226, 1993.
17. Dexter, T. M., Garland, J., Scott, D., Scolnick, E., and Metcalf, D. Growth of factor-dependent hemopoietic precursor cell lines. J. Exp. Med., 152: 1036-1047, 1980.
18. Peng, P., Menoret, A., and Srivastava, P. K. Purification of immunogenic heat shock protein 70-peptide complexes by ADP-affinity chromatography. J. Immunol. Methods, 204: 13-21, 1997.
19. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
20. Towbin, H., Staehelin, T., and Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA, 76: 4350-4354, 1979.
21. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
22. Peto, R., and Peto, J. Asymptotically efficient rank invariant test procedures. J. Royal Statistical Society Ser. A, A135: 185-207, 1972.
23. Basu, S., and Srivastava, P. K. Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity. J. Exp. Med., 189: 797-802, 1999.
24. Arnold, D., Faath, S., Rammensee, H., and Schild, H. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J. Exp. Med., 182: 885-889, 1995.
25. Nair, S., Wearsch, P. A., Mitchell, D. A., Wassenberg, J. J., Gilboa, E., and Nicchitta, C. V. Calreticulin displays in vivo peptide-binding activity and can elicit CTL responses against bound peptides. J. Immunol., 162: 6426-6432, 1999.
26. Srivastava, P. K., DeLeo, A. B., and Old, L. J. Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proc. Natl. Acad. Sci. USA, 83: 3407-3411, 1986.
27. Tamura, Y., Peng, P., Liu, K., Daou, M., and Srivastava, P. K. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science (Washington DC), 278: 117-120, 1997.
28. Udono, H., and Srivastava, P. K. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70. J. Immunol., 152: 5398-5403, 1994.
29. Ullrich, S. J., Robinson, E. A., Law, L. W., Willingham, M., and Appella, E. A mouse tumor-specific transplantation antigen is a heat shock-related protein. Proc. Natl. Acad. Sci. USA, 83: 3121-3125, 1986.
30. Glass, B., Uharek, L., Zeis, M., Loeffler, H., Mueller-Ruchholtz, W., and Gassmann, W. Graft-versus-leukaemia activity can be predicted by natural cytotoxicity against leukaemia cells. Br. J. Haematol., 93: 412-420, 1996.
31. Bausero, M. A., Panoskaltsismortari, A., Blazar, B. R., and Katsanis, E. Effective immunization against neuroblastoma using double-transduced tumor cells secreting GM-CSF interferon-gamma. J. Immunother., 19: 113-124, 1996.
32. Bronte, V., Chappell, D. B., Apolloni, E., Cabrelle, A., Wang, M., Hwu, P., and Restifo, N. P. Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation. J. Immunol., 162: 5728-5737, 1999.
33. Michalak, M., Milner, R. E., Burns, K., and Opas, M. Calreticulin. Biochem. J., 285: 681-692, 1992.
34. Dedhar, S. Novel functions for calreticulin: interaction with integrins and modulation of gene expression? Trends Biochem. Sci., 19: 269-271, 1994.
35. Burns, K., Duggan, B., Atkinson, E. A., Famulski, K. S., Nemer, M., Bleackley, R. C., and Michalak, M. Modulation of gene expression by calreticulin binding to the glucocorticoid receptor. Nature (Lond.), 367: 476-480, 1994.
36. Sontheimer, R. D., Nguyen, T. Q., Cheng, S. T., Lieu, T. S., and Capra, J. D. The unveiling of calreticulin-a clinically relevant tour of modern cell biology. J. Invest. Med., 43: 362-370, 1995.
37. Krause, K. H., and Michalak, M. Calreticulin. Cell, 88: 439-443, 1997.
38. Solheim, J. C., Harris, M. R., Kindle, C. S., and Hansen, T. H. Prominence of β2-microglobulin, class I heavy chain conformation, and tapasin in the interactions of class I heavy chain with calreticulin and the transporter associated with antigen processing. J. Immunol., 158: 2236-2241, 1997.
39. Sadasivan, B., Lehner, P. J., Ortmann, B., Spies, T., and Cresswell, P. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity, 5: 103-114, 1996.
40. Spee, P., and Neefjes, J. TAP-translocated peptides specifically bind proteins in the endoplasmic reticulum, including gp96, protein disulfide isomerase and calreticulin. Eur. J. Immunol., 27: 2441-2449, 1997.